Znanstveni rad - Pismo
Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone
Annals of Hematology, 102 (2022), 2; 499-500. https://doi.org/10.1007/s00277-022-05082-5

Bručić, Lana Jajac; Krečak, Ivan

Citirajte ovaj rad

Bručić, L. J. i Krečak, I. (2022). Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone. Annals of Hematology, 102. (2), 499-500. doi: 10.1007/s00277-022-05082-5

Bručić, Lana Jajac i Ivan Krečak. "Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone." Annals of Hematology, vol. 102, br. 2, 2022, str. 499-500. https://doi.org/10.1007/s00277-022-05082-5

Bručić, Lana Jajac i Ivan Krečak. "Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone." Annals of Hematology 102, br. 2 (2022): 499-500. https://doi.org/10.1007/s00277-022-05082-5

Bručić, L. J. i Krečak, I. (2022) 'Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone', Annals of Hematology, 102(2), str. 499-500. doi: 10.1007/s00277-022-05082-5

Bručić LJ, Krečak I. Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone. Annals of Hematology [Internet]. 20.12.2022. [pristupljeno 13.07.2024.];102(2):499-500. doi: 10.1007/s00277-022-05082-5

L. J. Bručić i I. Krečak, "Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone", Annals of Hematology, vol. 102, br. 2, str. 499-500, Prosinac 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:844867. [Citirano: 13.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.